Dr Tzuri Lifschytz Ph.D.

LifschytzAppointment: Research Scientist, Biological Psychiatry Laboratory

Area of expertise: Behavioral neurobiology, psychopharmacology

Tel: 02-6778120; Email: tzuri.lifschytz@mail.huji.ac.il

 

 

Selected Research Publications

Gur E, Lifschytz T, Lerer B, Newman ME (2002) Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. Eur J Pharmacol 457(1):37-43

Kehr J, institutet K (2003) Monitoring Molecules in Neuroscience: Proceedings of the 10th International Conference on In Vivo Methods : Karolinska Institutet, Stockholm, Sweden June 24-27, 2003. Karolinska University Press
Lifschytz T, Gur E, Lerer B, Newman ME (2004) Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140(1-2):133-139

Lifschytz T, Segman R, Shalom G, Lerer B, Gur E, Golzer T, Newman ME (2006) Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. Curr Drug Targets 7(2):203-210

Lifschytz T, Shalom G, Lerer B, Newman ME (2006) Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. Eur Neuropsychoph16(2):115-121

Ingram PDRE (2009) The International Encyclopedia of Depression. Springer Publishing Company
Eitan R, Landshut G, Lifschytz T, Einstein O, Ben-Hur T, Lerer B (2010) The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties. The International Journal of Neuropsychoph 13(05):553-561

Lifschytz T, Goltser-Dubner T, Landshut G, Lerer B (2010) Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test. Prog Neuropsychoph Biol Psychiatry 34(4):632-638

Lifschytz T, Zozulinsky P, Eitan R, Landshut G, Ohayon S, Lerer B (2010) Effect of triiodothyronine on antidepressant screening tests in mice and on presynaptic 5-HT1A receptors: mediation by thyroid hormone ־± receptors. J Pharmacol Exp Ther 337(2):494-502

Lifschytz T, Goltser-Dubner T, Landshut G, Lerer B (2010) Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test. Prog NeuropsychophBiol Psychiatry 34(4):632-638

Greenbaum L, Lifschytz T, Zozulinsky P, Broner EC, Slonimsky A, Kohn Y, Lerer B (2012) Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model. Eur Neuropsychoph22(5):379-386

Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, Greenbaum L, Lerer B (2012) Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement. The International Journal of Neuropsychoph 15(09):1307-1318

Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifshytz T, Kohn Y, Djaldetti R, Lerer B (2012) Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients. Psychoph (Berl) 220(3):519-528

Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen OS, Yahalom G, Cilia R, Tesei S, Asselta R, Inzelberg R (2013) Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study. J Mol Neurosci 51(2):380-388

Lotan A, Lifschytz T, Slonimsky A, Broner E, Greenbaum L, Abedat S, Fellig Y, Cohen H, Lory O, Goelman G (2014)  Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders. Mol Psychiatry 19(2):243-252